New smart system aims to catch dangerous blood pressure drops earlier
NCT ID NCT07309666
First seen Jan 08, 2026 · Last updated Jun 21, 2026 · Updated 28 times
Summary
This study will test a new intelligent diagnostic system for orthostatic hypotension (a sudden drop in blood pressure when standing up). The system continuously monitors blood pressure, brain blood flow, and heart signals to classify the condition more precisely. Researchers plan to enroll 2000 adults with Parkinson's disease, multiple system atrophy, or diabetes who may have orthostatic hypotension. The goal is to create a risk-stratification model that could improve early detection and management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORTHOSTATIC HYPOTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Intelligent diagnostic system (non-invasive monitoring of blood pressure, brain blood flow, and heart signals)
What this could lead to
If successful, this could lead to a more accurate and automated way to diagnose and classify orthostatic hypotension, potentially reducing falls and disability in elderly and at-risk patients.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The system may not prove accurate enough for widespread use, and results may not apply to all patient groups.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.